Delivery Order SPE2DR25D3103-SPE2DR26F9M87
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,255.47 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on November 7, 2025, with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.88 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.20 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,384.94 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on December 18, 2025, with completion targeted for December 19, 2025. This is a firm fixed-price contract with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $9,093.31 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal military...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.79 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-spray units). The contract carries a firm fixed price and is scheduled for completion by December 12, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability...
- The Defense Logistics Agency awarded a $3,834.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-dose units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,622.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on November 28, 2025, with an ultimate completion date of December 1, 2025. This award is a non-set-aside contract and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026....
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M87Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,641.54 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive range of medications and medical commodities across multiple therapeutic domains. The company's robust federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to support global pharmaceutical needs across military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/7/25 |